Hexokinase Antikörper (AA 1-917)
Kurzübersicht für Hexokinase Antikörper (AA 1-917) (ABIN7596072)
Target
Alle Hexokinase Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-917
-
Verwendungszweck
- Human Hexokinase antibody
-
Aufreinigung
- protein-A affinity chromatography
-
Immunogen
- Recombinant human Hexokinase1 (1-917aa) purified from E. coli
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% glycero
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
-
-
- Hexokinase
-
Hintergrund
- Hexokinase is the first enzyme in the glycolytic pathway, catalyzing the transfer of a phosphoryl group fromATP to glucose to form glucose-6-phosphate and ADP. In mammals, four distinct enzymes-types 1 to 4hexokinases-have been identified. The enzyme is found in most cells, but there is tissue specificity for theparticular type of hexokinase. Hexokinase1 is found in the adipose tissue and liver and encodes a ubiquitous formof hexokinase which localizes to the outer membrane of mitochondria. Mutations in this hexokinase1 have beenassociated with hemolytic anemia due to hexokinase deficiency.
-
NCBI Accession
- NP_000179
Target
-